AMDCP Credit Designation: This session has been approved for a total of 3 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): Eric Tangalos, MD, CMD;Ladislav Volicer, MD, PhD; Joyce Simard, MSW; Mara Ferris, RN, GCNS-BC; Leo J.Borrell, MD Disclosure(s): LeoJ. Borrell, MD will discuss substances not approvedin the USfor use under discussion - Trazadone AbilifyDepakote Trazadone Amita Patel, MD received speakerhonoraria from Eli Lilly and Company, Sanofi Aventis,Bros, and WyethPharmaceuticals and a consultant fee from Eli Lilly and Company. Products madeby these companies related to this topic: Cymbalta, Ambien CR, Abilify and Pristiq. EricTangalos, MD, CMD received a consultant fee from Novartis, a Data MonitoringCommittee fee from Eli Lilly and Company, and an investigator fee from Elan Pharmaceuticals, Inc. Product(s) made by thesecompanies related to this topic: Exelon, Bapineuzumab. JoyceSimard, MSW received author royalties for a book from Health Profession Press.
Allother presenters reported they had no relevant financial relationships todisclose. Session Description: This session makes the case for a comprehensivemulti-disciplinary care approach for treatment of the complex behavioraldisturbances that can occur relative to many situations and conditions ingero-psychiatric patients. For instance, behaviors that are consideredaggressive are very common in patients with Alzheimer's disease occurring inabout 40-90% of patients during the course of their illness. Certain riskfactors include environment, stage of dementia, psychiatric diagnosis,co-morbid medical conditions and psychosocial factors. The challenges of andstrategies for this ideal treatment approach are discussed. Learning Objectives:
Discuss how agitation and resistiveness to care are mistaken asaggression
Identify various behavioral approaches such as how continuousactivities for patients with dementia can decrease isolation, psychotropicmedication use and behavioral disturbances
Describe barriers related to organizational changes andimplementation of behavior management
Explain how to train staff in behavior management using amulti-disciplinary care approach
References: 1. "An Introduction to Belbin Team Roles", byBernard Chanliau 2. Competetive Strategy, Michael Porter. 3. "Effects of Continuous Activities Programming onBehavioral Symptoms of Dementia" L.Volicer at al. J Am Med Dir Assoc,2006: 7: 426-431. 4. Volicer L, Bass EA, Luther SL. Agitation and resistivenessto care are two separate behavioral syndromes of dementia. J Am Med Dir Assoc.8(8):527-32, 2007. 5. Rogers, EverettM. Diffusion of Innovations, (5th ed.). (2003) New York : Free Press. The Anatomy of Buzz:How to Create Word of Mouth Marketing by Emanuel Rosen. The Structure ofScientific Revolutions (1962) publ. Universityof Chicago Press, MichaelKuhns 1962.